These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 21080969

  • 1. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
    Han JS, Crowe DL.
    BMC Cancer; 2010 Nov 16; 10():629. PubMed ID: 21080969
    [Abstract] [Full Text] [Related]

  • 2. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
    Buroker NE, Barboza J, Huang JY.
    FEBS J; 2009 Jun 16; 276(12):3247-55. PubMed ID: 19438714
    [Abstract] [Full Text] [Related]

  • 3. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL, Chandraratna RA.
    Breast Cancer Res; 2004 Jun 16; 6(5):R546-55. PubMed ID: 15318936
    [Abstract] [Full Text] [Related]

  • 4. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson JA.
    Mol Endocrinol; 1998 Jun 16; 12(6):864-81. PubMed ID: 9626662
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
    DiRenzo J, Söderstrom M, Kurokawa R, Ogliastro MH, Ricote M, Ingrey S, Hörlein A, Rosenfeld MG, Glass CK.
    Mol Cell Biol; 1997 Apr 16; 17(4):2166-76. PubMed ID: 9121466
    [Abstract] [Full Text] [Related]

  • 6. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 16; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M, Tanen MR, Bagchi MK.
    Mol Endocrinol; 1997 Jun 16; 11(6):755-67. PubMed ID: 9171239
    [Abstract] [Full Text] [Related]

  • 8. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
    Ku TK, Crowe DL.
    J Endocrinol; 2007 Apr 16; 193(1):147-55. PubMed ID: 17400812
    [Abstract] [Full Text] [Related]

  • 9. Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1.
    Chaudhry AZ, Vitullo AD, Gronostajski RM.
    J Biol Chem; 1999 Mar 12; 274(11):7072-81. PubMed ID: 10066764
    [Abstract] [Full Text] [Related]

  • 10. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.
    Qin L, Liu Z, Chen H, Xu J.
    Cancer Res; 2009 May 01; 69(9):3819-27. PubMed ID: 19383905
    [Abstract] [Full Text] [Related]

  • 11. Dasatinib inhibits mammary tumour development in a genetically engineered mouse model.
    Karim SA, Creedon H, Patel H, Carragher NO, Morton JP, Muller WJ, Evans TR, Gusterson B, Sansom OJ, Brunton VG.
    J Pathol; 2013 Aug 01; 230(4):430-40. PubMed ID: 23616343
    [Abstract] [Full Text] [Related]

  • 12. Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
    Brown PH, Subbaramaiah K, Salmon AP, Baker R, Newman RA, Yang P, Zhou XK, Bissonnette RP, Dannenberg AJ, Howe LR.
    Cancer Prev Res (Phila); 2008 Aug 01; 1(3):208-14. PubMed ID: 19138958
    [Abstract] [Full Text] [Related]

  • 13. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
    Kong G, Kim HT, Wu K, DeNardo D, Hilsenbeck SG, Xu XC, Lamph WW, Bissonnette R, Dannenberg AJ, Brown PH.
    Cancer Res; 2005 Apr 15; 65(8):3462-9. PubMed ID: 15833882
    [Abstract] [Full Text] [Related]

  • 14. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
    Monden T, Yamada M, Nihei Y, Kishi M, Tomaru T, Ishii S, Hashida T, Shibusawa N, Hashimoto K, Satoh T, Kasai K, Mori M.
    Life Sci; 2004 Dec 31; 76(7):731-41. PubMed ID: 15581905
    [Abstract] [Full Text] [Related]

  • 15. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H, Kuang SQ, Liao L, Zhou S, Xu J.
    Cancer Res; 2004 Oct 01; 64(19):7169-77. PubMed ID: 15466215
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C, Zhu Y, Reddy JK.
    Cell Biochem Biophys; 2000 Oct 01; 32 Spring():187-204. PubMed ID: 11330046
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
    Lee KC, Li J, Cole PA, Wong J, Kraus WL.
    Mol Endocrinol; 2003 May 01; 17(5):908-22. PubMed ID: 12586842
    [Abstract] [Full Text] [Related]

  • 18. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
    Zhou G, Cummings R, Li Y, Mitra S, Wilkinson HA, Elbrecht A, Hermes JD, Schaeffer JM, Smith RG, Moller DE.
    Mol Endocrinol; 1998 Oct 01; 12(10):1594-604. PubMed ID: 9773982
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
    Lu Y, Bertran S, Samuels TA, Mira-y-Lopez R, Farias EF.
    Oncogene; 2010 Jun 24; 29(25):3665-76. PubMed ID: 20453882
    [Abstract] [Full Text] [Related]

  • 20. Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
    Yee LD, Young DC, Rosol TJ, Vanbuskirk AM, Clinton SK.
    J Nutr; 2005 May 24; 135(5):983-8. PubMed ID: 15867269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.